Impact of acute kidney injury in patients prescribed angiotensin-converting enzyme inhibitors over the first two years of life
- 19 January 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Pediatric Nephrology
- Vol. 36 (7), 1907-1914
- https://doi.org/10.1007/s00467-021-04920-4
Abstract
Background The association of long-term acute kidney injury (AKI) risk with angiotensin-converting enzyme (ACE) inhibitor use in neonates/infants is poorly understood. We examined this association to identify potential AKI risk factors. Methods We retrospectively evaluated 119 children aged < 2 years (72 boys; median age, 5.0 months) who received ACE inhibitors for congenital heart disease for ≥ 6 months between January 2009 and June 2019. We monitored the occurrence of AKI, defined according to the Kidney Disease Improving Global Outcomes guidelines. Demographic and clinical data were extracted from medical records. Risk factors associated with AKI onset were identified by a Cox proportional hazards regression analysis of variables previously identified as risk factors of AKI and those significant in a univariate analysis. Results Thirty-three of 119 patients (28%) developed AKI at a median follow-up of 1.3 years (interquartile range, 0.8–3.2 years). AKI incidence was 1257 events per 10,000 patient-years. Concomitant tolvaptan use (hazard ratio [HR], 3.81; 95% confidence interval [CI], 1.82–7.97; P < 0.01) and Down syndrome (HR, 3.22; 95% CI, 1.43–7.29; P < 0.01) were identified as independent risk factors of AKI onset. Conclusions AKI was strongly associated with concomitant tolvaptan use and Down syndrome in our study population. Physicians should consider these factors when prescribing ACE inhibitors for neonates/infants. Low-dose ACE inhibitors slow CKD progression because of their antifibrotic properties. ACE inhibitors may be beneficial for patients with Down syndrome who have underlying CKD in a non-acute setting. Therefore, they should be administered to such patients with caution.Keywords
This publication has 51 references indexed in Scilit:
- NoticeKidney International Supplements, 2012
- An acute fall in estimated glomerular filtration rate during treatment with losartan predicts a slower decrease in long-term renal functionKidney International, 2011
- Acute fall in glomerular filtration rate with renin–angiotensin system inhibition: a biomeasure of therapeutic success?Kidney International, 2011
- New Equations to Estimate GFR in Children with CKDJournal of the American Society of Nephrology, 2009
- Human microRNA-155 on Chromosome 21 Differentially Interacts with Its Polymorphic Target in the AGTR1 3′ Untranslated Region: A Mechanism for Functional Single-Nucleotide Polymorphisms Related to PhenotypesAmerican Journal of Human Genetics, 2007
- A multicenter study of the pharmacokinetics of lisinopril in pediatric patients with hypertensionPediatric Nephrology, 2007
- Epidemiology of Down syndromeMental Retardation and Developmental Disabilities Research Reviews, 2007
- Renal involvement in Down syndromePediatric Nephrology, 2005
- Low Blood Pressure in Down's SyndromeHypertension, 1996
- Prerenal Failure: A Deleterious Shift from Renal Compensation to DecompensationThe New England Journal of Medicine, 1988